Livanova Plc (LIVN) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Livanova Plc  (NASDAQ: LIVN)

Livanova Plc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Livanova Plc in the second quarter 2026?
Livanova Plc achieved a return on average equity (ROE) of 15.41 % in its second quarter 2026 a new company high.

ROE has advanced compared to 9.14% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 24 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1539, from total ROE ranking in the first quarter 2026 at 1579.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 18.03 % 17.12 % -9.11 % -11.66 % -
Y / Y Net Income Change 299.72 % - -44.7 % -18.72 % 66.3 %
Net Income (TTM) in Millions 189 107 -242 -217 -211
Return On Equity (TTM) 15.41 % 9.14 % -21.48 % -18.77 % -17.66 %
LIVN's Total Ranking # 1539 # 1579 # 2034 # 2579 #
Equity (TTM) in Millions 1,325 1,211 1,200 1,157 1,123
Seq. Equity Change 9.41 % 0.94 % 3.69 % 3.06 % 8.56 %
Seq. Net Income Change 386.99 % -27.87 % 15.39 % -1.39 % -

Back to LIVN Management Effectiveness >> LIVN's 5 Years Annual ROE >> Compare LIVN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 25
Sector # 106
Overall # 1539

Return On Equity Statistics
High Average Low
15.41 %
-7.66 %
-36.66 %
(Jun 30 2026)   (Sep 30 2021)





LIVN Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 1,200 1,320 1,278 1,208 1,295
Y / Y Equity Change -9.11 % 3.34 % 5.8 % -6.72 % 16.71 %
Net Income in Millions -242 63 18 -86 -136
Y / Y Net Income Change - 260.39 % - - -
Return On Equity -20.21 % 4.79 % 1.37 % -7.14 % -10.49 %

Back to LIVN Management Effectiveness >> LIVN's 5 Years Annual ROE >> Compare LIVN ROE to its Competitors




More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LIVN's' Return on Equity at Yahoo Finance
LIVN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LIVN's Competitors
Subscribers only: Roe for Livanova Plc's Suppliers
Subscribers only: Return On Equity for LIVN's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Agilent Technologies inc   41.99 %
Eton Pharmaceuticals Inc   40.13 %
Adma Biologics Inc   39.59 %
Dexcom Inc   36.25 %
Transmedics Group Inc   33.37 %
Arcutis Biotherapeutics Inc   32.92 %
Caredx Inc   32.81 %
Zevra Therapeutics Inc   32.56 %
Acadia Pharmaceuticals Inc   32.39 %
Pro dex Inc   31.96 %
Protalix Biotherapeutics inc   31.61 %
Illumina Inc   31.08 %
Innoviva Inc   30.03 %
Phibro Animal Health Corporation  29.66 %
Chemed Corporation  29.45 %
Solventum Corporation  28.96 %
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %

Date modified: 2026-09-09T22:39:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.